Effects of sialic acid residues of transferrin on the binding with aluminum and iron studied by HPLC/high-resolution ICP-MS

Biochimica et Biophysica Acta - General Subjects

Volumn 1526, Issue 2, 2001, Pages 175-182

  Hamano Nagaoka, Megumi ^a   Maitani, Tamio ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Aluminum; Carbohydrate deficient transferrin; High resolution inductively coupled plasma mass spectrometry; Iron; Sialidase; Transferrin

Indexed keywords

ALUMINUM; ALUMINUM CITRATE; ALUMINUM DERIVATIVE; ALUMINUM OXALATE; ASIALOTRANSFERRIN; BICARBONATE; CARBOHYDRATE DEFICIENT TRANSFERRIN; FERRIC ION; GLYCAN; IRON BINDING PROTEIN; IRON CITRATE; IRON DERIVATIVE; IRON OXALATE; SIALIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BLOOD ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT ABSORPTION; MASS SPECTROMETRY; METAL BINDING; PRIORITY JOURNAL; STOICHIOMETRY;

ALUMINUM; BICARBONATES; BINDING SITES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FERRIC COMPOUNDS; HUMANS; IRON; MASS SPECTROMETRY; N-ACETYLNEURAMINIC ACID; OXALATES; TRANSFERRIN;

EID: 0343408359     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(01)00124-6     Document Type: Article

References (45)

1. Golub M.S., Han B., Keen C.L., Gershwin M.E. Effects of dietary aluminum excess and manganese deficiency on neurobehavioral endpoints in adult mice. Toxicol. Appl. Pharmacol. 112:1992;154-160.
2. Harrington C.R., Wischik C.M., McArthur F.K., Taylor G.A., Edwardson J.A., Candy J.M. Alzheimer's-disease-like changes in τ protein processing association with aluminium accumulation in brains of renal dialysis patients. Lancet. 343:1994;993-997.
3. Aramini J.M., Saponja J.A., Vogel H.J. Spectroscopic studies of the interaction of aluminum(III) with transferrins. Coord. Chem. Rev. 149:1996;193-229.
4. Bailey S., Evans R.W., Garratt R.C., Gorinsky B., Hasnain S., Horsburgh C., Jhoti H., Lindley P.F., Mydin A., Sarra R., Watson J.L. Molecular structure of serum transferrin at 3.3-Å resolution. Biochemistry. 27:1988;5804-5812.
5. Anderson B.F., Baker H.M., Norris G.E., Rumball S.V., Baker E.N. Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins. Nature. 344:1990;784-787.
6. Baker E.N., Anderson B.F., Baker H.M., Haridas M., Jameson G.B., Norris G.E., Rumball S.V., Smith C.A. Structure, function and flexibility of human lactoferrin. Int. J. Biol. Macromol. 13:1991;122-129.
7. MacGillivray R.T., Mendez E., Shewale J.G., Sinha S.K., Lineback-Zins J., Brew K. The primary structure of human serum transferrin. The structures of seven cyanogen bromide fragments and the assembly of the complete structure. J. Biol. Chem. 258:1983;3543-3553.
8. Rohrer J.S., Avdalovic N. Separation of human serum transferrin isoforms by high-performance pellicular anion-exchange chromatography. Protein Expr. Purif. 7:1996;39-44.
9. de Jong G., van Dijk J.P., van Eijk H.G. The biology of transferrin. Clin. Chim. Acta. 190:1990;1-46.
10. Yang L., Tang Q., Harrata A.K., Lee C.S. Capillary isoelectric focusing-electrospray ionization mass spectrometry for transferrin glycoforms analysis. Anal. Biochem. 243:1996;140-149.
11. Yamashita K., Ideo H., Ohkura T., Fukushima K., Yuasa I., Ohno K., Takeshita K. Sugar chains of serum transferrin from patients with carbohydrate deficient glycoprotein syndrome. Evidence of asparagine-N-linked oligosaccharide transfer deficiency. J. Biol. Chem. 268:1993;5783-5789.
12. Spik G., Bayard B., Fournet B., Strecker G., Bouquelet S., Montreuil J. Studies on glycoconjugates. LXIV. Complete structure of two carbohydrate units of human serotransferrin. FEBS Lett. 50:1975;296-299.
13. Landberg E., Pahlsson P., Lundblad A., Arnetorp A., Jeppsson J.O. Carbohydrate composition of serum transferrin isoforms from patients with high alcohol consumption. Biochem. Biophys. Res. Commun. 210:1995;267-274.
14. Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin. Chem. 37:1991;2029-2037.
15. Mihas A.A., Tavassoli M. Laboratory markers of ethanol intake and abuse: a critical appraisal. Am. J. Med. Sci. 303:1992;415-428.
16. Rosman A.S., Lieber C.S. Diagnostic utility of laboratory tests in alcoholic liver disease. Clin. Chem. 40:1994;1641-1651.
17. Inoue T., Yamauchi M., Ohkawa K. Structural studies on sugar chains of carbohydrate-deficient transferrin from patients with alcoholic liver disease using lectin affinity electrophoresis. Electrophoresis. 20:1999;452-457.
18. Xin Y., Lasker J.M., Lieber C.S. Serum carbohydrate-deficient transferrin: mechanism of increase after chronic alcohol intake. Hepatology. 22:1995;1462-1468.
19. Sillanaukee P., Ponnio M., Seppa K. Sialic acid: new potential marker of alcohol abuse. Alcohol Clin. Exp. Res. 23:1999;1039-1043.
20. Sonmez H., Ozturk Z.G., Ulutin T., Domanic N., Kokoglu E. Carbohydrate-deficient transferrin and sialidase levels in coronary heart disease. Thromb. Res. 99:2000;311-315.
21. Lobinski R., Szpunar J. Biochemical speciation analysis by hyphenated techniques. Anal. Chim. Acta. 400:1999;321-332.
22. Jakubowski N., Moens L., Vanhaecke F. Sector field mass spectrometers in ICP-MS. Spectrochim. Acta B. 53:1998;1739-1763.
23. Giessmann U., Greb U. High resolution ICP-MS: a new concept for elemental mass spectrometry. Fresenius J. Anal. Chem. 350:(007):1994;186-193.
24. Yoshinaga J., Shibata Y., Uehiro T., Morita M., Kaneko T., Iwanaga M., Ohtsuka K. Determination of aluminum in serum by inductively coupled plasma high resolution mass spectrometry (ICP-MS). Biomed. Res. Trace Elem. 5:1994;259-260.
25. de Jong G., Ammerlaan C.C., van Noort W.L., van Eijk H.G., van Landeghem G.L., D'Haese P.C., de Broe M.E. An in vitro study on the binding of Al(III) to human serum transferrin with the isoelectric focusing technique. Biometals. 8:1995;352-356.
26. Warren L. The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234:1959;1971-1975.
27. Nagaoka M.H., Maitani T. Binding patterns of co-existing aluminium and iron to human serum transferrin studied by HPLC/high resolution ICP-MS. Analyst. 125:2000;1962-1965.
28. Chasteen N.D., Williams J. The influence of pH on the equilibrium distribution of iron between the metal-binding sites of human transferrin. Biochem. J. 193:1981;717-727.
29. Nagaoka M.H., Maitani T. Differed preferential iron-binding lobe in human transferrin depending on the presence of bicarbonate detected by HPLC/high-resolution inductively coupled plasma mass spectrometry. Biochim. Biophys. Acta. 1523:2000;182-188.
30. Gaulier J.M., Cochat P., Lardet G., Vallon J.J. Serum oxalate microassay using chemiluminescence detection. Kidney Int. 52:1997;1700-1703.
31. Baker H.M., Anderson B.F., Brodie A.M., Shongwe M.S., Smith C.A., Baker E.N. Anion binding by transferrins: importance of second-shell effects revealed by the crystal structure of oxalate-substituted diferric lactoferrin. Biochemistry. 35:1996;9007-9013.
32. Aisen P., Leibman A., Zweier J. Stoichiometric and site characteristics of the binding of iron to human transferrin. J. Biol. Chem. 253:1978;1930-1937.
33. Harris W.R., Sheldon J. Equilibrium constants for the binding of aluminum to human serum transferrin. Inorg. Chem. 29:1990;119-124.
34. Hoefkens P., Huijskes-Heins M.I., de Jeu-Jaspars C.M., van Noort W.L., van Eijk H.G. Influence of transferrin glycans on receptor binding and iron-donation. Glycoconjug. J. 14:1997;289-295.
35. Bastani B., Mistry B.M., Nahass G.T., Joh J., Dundoo G., Solomon H. Oxalate kinetics and reversal of the complications after orthotopic liver transplantation in a patient with primary hyperoxalosis type 1 awaiting renal transplantation. Am. J. Nephrol. 19:1999;64-69.
36. Young S.P., Bomford A., Williams R. The effect of the iron saturation of transferrin on its binding and uptake by rabbit reticulocytes. Biochem. J. 219:1984;505-510.
37. Marangella M., Petrarulo M., Vitale C., Daniele P.G., Sammartano S., Cosseddu D., Linari F. Serum calcium oxalate saturation in patients on maintenance haemodialysis for primary hyperoxaluria or oxalosis-unrelated renal diseases. Clin. Sci. 81:1991;483-490.
38. Rudd P.M., Dwek R.A. Glycosylation: heterogeneity and the 3D structure of proteins. Crit. Rev. Biochem. Mol. Biol. 32:1997;1-100.
39. Grossmann J.G., Neu M., Pantos E., Schwab F.J., Evans R.W., Townes-Andrews E., Lindley P.F., Appel H., Thies W.G., Hasnain S.S. X-ray solution scattering reveals conformational changes upon iron uptake in lactoferrin, serum and ovo-transferrins. J. Mol. Biol. 225:1992;811-819.
40. MacGillivray R.T., Bewley M.C., Smith C.A., He Q.-Y., Mason A.B., Woodworth R.C., Baker E.N. Mutation of the iron ligand His249 to Glu in the N-lobe of human transferrin abolishes the dilysine 'trigger' but does not significantly affect iron release. Biochemistry. 39:2000;1211-1216.
41. He Q.-Y., Mason A.B., Tam B.M., MacGillivray R.T., Woodworth R.C. Dual role of Lys206-Lys296 interaction in human transferrin N-lobe iron-release trigger and anion-binding site. Biochemistry. 38:1999;9704-9711.
42. Moos T., Morgan E.H. Transferrin and transferrin receptor function in brain barrier systems. Cell. Mol. Neurobiol. 20:2000;77-95.
43. Yajima H., Sakajiri T., Kikuchi T., Morita M., Ishii T. Molecular modeling of human serum transferrin for rationalizing the changes in its physicochemical properties induced by iron binding. Implication of the mechanism of binding to its receptor. J. Protein Chem. 19:2000;215-223.
44. Renner F., Kanitz R.D. Quantification of carbohydrate-deficient transferrin by ion-exchange chromatography with an enzymatically prepared calibrator. Clin. Chem. 43:1997;485-490.
45. Mason A.B., Miller M.K., Funk W.D., Banfield D.K., Savage K.J., Oliver R.W., Green B.N., MacGillivray R.T., Woodworth R.C. Expression of glycosylated and nonglycosylated human transferrin in mammalian cells. Characterization of the recombinant proteins with comparison to three commercially available transferrins. Biochemistry. 32:1993;5472-5479.